Carl Dambkowski Arca Biopharma, Inc. (ABIO) insider trading activity

ABIO Quotes by TradingView

Carl Dambkowski is Director of ARCA biopharma, Inc.. Currently has a direct ownership of 116,483 shares of ABIO, which is worth approximately $0. The most recent transaction as insider was on Jan 23, 2026, when has been sold 116,483 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 116K
n/a 3M change
n/a 12M change
Total Value Held $0

Carl Dambkowski Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 23 2026
BUY
Other acquisition or disposition
-
116,483 Added 50.0%
116,483 Common Stock

Also insider at

APGE
Apogee Therapeutics, Inc.
Chief Medical Officer
CD

Carl Dambkowski

Director
Waltham, MA

Track Institutional and Insider Activities on ABIO

Follow ARCA biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABIO shares.

Notify only if

Insider Trading

Get notified when an Arca Biopharma, Inc. insider buys or sells ABIO shares.

Notify only if

News

Receive news related to ARCA biopharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ABIO